NCT01664039View on ClinicalTrials.gov

An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®

PHASE4CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004% ophthalmic solution

Ophthalmic solution without benzalkonium chloride (BAK), containing Polyquad® preservative

DRUG

Bimatoprost 0.01% ophthalmic solution

Ophthalmic solution containing benzalkonium chloride (BAK)

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY